Literature DB >> 18536926

TDP-43-negative FTLD-U is a significant new clinico-pathological subtype of FTLD.

Sigrun Roeber1, Ian R A Mackenzie, Hans A Kretzschmar, Manuela Neumann.   

Abstract

Frontotemporal lobar degeneration with ubiquitin-positive inclusions (FTLD-U) is the most common neuropathological subtype of frontotemporal dementias. While TDP-43 is the pathologic protein in the majority of FTLD-U cases, small numbers of cases have recently been reported with TDP-43-negative FTLD-U pathology. To determine the frequency and to define the clinico-pathological spectrum of TDP-43-negative FTLD-U, we re-evaluated 44 cases with a previous diagnosis of FTLD-U or dementia lacking distinctive histopathology. We identified nine cases (20%) with TDP-43-negative FTLD-U pathology by immunohistochemistry and confirmed the absence of pathological TDP-43 by biochemical analysis. All patients presented with sporadic early-onset frontotemporal dementia with predominant behavioral and personality changes. Besides ubiquitin-positive neuronal cytoplasmic inclusions, the most intriguing neuropathological feature was the presence of ubiquitin-positive neuronal intranuclear inclusions (NIIs), often with curved or twisted morphology, in the neocortex, hippocampus, brainstem, and spinal cord. Double-label immunofluorescence revealed an unusual and distinct immunoreactivity profile for these NIIs, with ubiquitin-immunoreactivity, but absence of p62 labeling. The highly consistent clinical and neuropathological phenotype supports the concept that TDP-43-negative FTLD-U should be considered as a new clinicopathological FTLD entity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18536926     DOI: 10.1007/s00401-008-0395-x

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  40 in total

Review 1.  Advances in understanding the molecular basis of frontotemporal dementia.

Authors:  Rosa Rademakers; Manuela Neumann; Ian R Mackenzie
Journal:  Nat Rev Neurol       Date:  2012-06-26       Impact factor: 42.937

2.  Caudate atrophy on MRI is a characteristic feature of FTLD-FUS.

Authors:  K A Josephs; J L Whitwell; J E Parisi; R C Petersen; B F Boeve; C R Jack; D W Dickson
Journal:  Eur J Neurol       Date:  2010-03-03       Impact factor: 6.089

3.  Clinical characterization of bvFTD due to FUS neuropathology.

Authors:  Suzee E Lee; William W Seeley; Pardis Poorzand; Rosa Rademakers; Anna Karydas; Christine M Stanley; Bruce L Miller; Katherine P Rankin
Journal:  Neurocase       Date:  2011-11-07       Impact factor: 0.881

4.  TAR DNA-binding protein-43 in amyotrophic lateral sclerosis, frontotemporal lobar degeneration, and Alzheimer disease.

Authors:  Eileen H Bigio
Journal:  Acta Neuropathol       Date:  2008-06-25       Impact factor: 17.088

Review 5.  TDP-43 and frontotemporal dementia.

Authors:  William T Hu; Murray Grossman
Journal:  Curr Neurol Neurosci Rep       Date:  2009-09       Impact factor: 5.081

6.  Abundant FUS-immunoreactive pathology in neuronal intermediate filament inclusion disease.

Authors:  Manuela Neumann; Sigrun Roeber; Hans A Kretzschmar; Rosa Rademakers; Matt Baker; Ian R A Mackenzie
Journal:  Acta Neuropathol       Date:  2009-08-09       Impact factor: 17.088

Review 7.  Review: transactive response DNA-binding protein 43 (TDP-43): mechanisms of neurodegeneration.

Authors:  T F Gendron; K A Josephs; L Petrucelli
Journal:  Neuropathol Appl Neurobiol       Date:  2010-02-19       Impact factor: 8.090

Review 8.  On the development of markers for pathological TDP-43 in amyotrophic lateral sclerosis with and without dementia.

Authors:  F Geser; D Prvulovic; L O'Dwyer; O Hardiman; P Bede; A L W Bokde; J Q Trojanowski; H Hampel
Journal:  Prog Neurobiol       Date:  2011-09-03       Impact factor: 11.685

9.  Pathological heterogeneity in amyotrophic lateral sclerosis with FUS mutations: two distinct patterns correlating with disease severity and mutation.

Authors:  Ian R A Mackenzie; Olaf Ansorge; Michael Strong; Juan Bilbao; Lorne Zinman; Lee-Cyn Ang; Matt Baker; Heather Stewart; Andrew Eisen; Rosa Rademakers; Manuela Neumann
Journal:  Acta Neuropathol       Date:  2011-05-21       Impact factor: 17.088

Review 10.  The role of transactive response DNA-binding protein-43 in amyotrophic lateral sclerosis and frontotemporal dementia.

Authors:  Ian R A Mackenzie; Rosa Rademakers
Journal:  Curr Opin Neurol       Date:  2008-12       Impact factor: 5.710

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.